Monoclonal Antibodies in Hapten Immunoassays

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 1992 Nov 1

PMID 1475221

Citations 4

Authors

O N Chappey

P Sandouk

J M Scherrmann

Affiliations

Soon will be listed here.

Abstract

This review deals with the potency of monoclonal antibodies (MAbs) to haptens in immunoassays. Specificity and affinity of MAbs to haptens are the major determinants to be considered. Specificity of MAbs depends on the selection of the hapten coupling site to the carrier protein and the antigen used for the screening of MAbs. Nevertheless, cross-reactivity can occur with compounds related to the hapten. This polyspecificity may be circumvented with the use of many MAbs, as has been demonstrated for MAbs to cyclosporine. Affinity of MAbs to haptens is often lower than that of corresponding polyclonal antibodies (PAbs), thereby limiting assay sensitivity. Low affinity is more frequently observed with low molecular weight (100-300) haptens than with larger haptens, such as digoxin or cyclosporine. Affinity enhancement by increasing resemblance to the immunogen can be effective in resolving the lack of sensitivity. With suitable selection strategies. MAbs exhibit real advantages over classical PAbs to haptens because large amounts of worldwide standardized reagents can be prepared.

Citing Articles

Synthesis of Zearalenone Immunogen and Comparative Analysis of Antibody Characteristics.

Wang Y, Wang X, Zhang H, Jiang J, Fotina H Int J Anal Chem. 2021; 2021:7109383.

PMID: 34349801 PMC: 8328739. DOI: 10.1155/2021/7109383.

Enhancers Improve the AID-Induced Hypermutation in Episomal Vector for Antibody Affinity Maturation in Mammalian Cell Display.

Chen C, Wang J, Zhao Y, Chen S, Hu Z, Chen L Antibodies (Basel). 2019; 7(4).

PMID: 31544892 PMC: 6698961. DOI: 10.3390/antib7040042.

Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib.

Sogawa R, Saita T, Yamamoto Y, Kimura S, Narisawa Y, Kimura S J Pharm Anal. 2019; 9(1):49-54.

PMID: 30740257 PMC: 6355467. DOI: 10.1016/j.jpha.2018.09.002.

Stereoselectivity of antibodies for the bioanalysis of chiral drugs.

Got P, Scherrmann J Pharm Res. 1998; 14(11):1516-23.

PMID: 9434269 DOI: 10.1023/a:1012161814494.

References

Cailla H, Delaage M . Adenosine 3',5' cyclic monophosphate assay at 10-15 mole level. Anal Biochem. 1973; 56(2):394-407. DOI: 10.1016/0003-2697(73)90205-4. View

Hunter M, Margolies M, Ju A, Haber E . High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. J Immunol. 1982; 129(3):1165-72. View

Lane D, KOPROWSKI H . Molecular recognition and the future of monoclonal antibodies. Nature. 1982; 296(5854):200-2. DOI: 10.1038/296200a0. View

Buffiere F, Cook-Moreau J, Gualde N, Rigaud M . Purification and characterization of monoclonal antibodies to alpha-linolenic acid. J Lipid Mediat. 1989; 1(2):139-47. View

Pincus S, Watson W, Harris S, Ewing L, Stocks C, Rollins D . Phenotypic and genotypic characterization of monoclonal anti-digoxin antibodies. Life Sci. 1984; 35(4):433-40. DOI: 10.1016/0024-3205(84)90654-4. View

Ekins R . Radioimmunoassay and saturation analysis. Basic principles and theory. Br Med Bull. 1974; 30(1):3-11. DOI: 10.1093/oxfordjournals.bmb.a071163. View

Richards F, Konigsberg W, Rosenstein R, VARGA J . On the specificity of antibodies. Science. 1975; 187(4172):130-7. DOI: 10.1126/science.46122. View

Kyurkchiev S, Tyutyullkova S, Kehayov I . Selection of monoclonal anti-digoxin antibodies with appropriate binding characteristics for immunodiagnostic purposes. Methods Find Exp Clin Pharmacol. 1990; 12(4):265-74. View

Kelly K . Ranitidine cross-reactivity in the EMIT d.a.u. Monoclonal Amphetamine/Methamphetamine Assay. Clin Chem. 1990; 36(7):1391-2. View

10.

Quesniaux V, Tees R, SCHREIER M, Maurer G, Van Regenmortel M . Potential of monoclonal antibodies to improve therapeutic monitoring of cyclosporine. Clin Chem. 1987; 33(1):32-7. View

11.

Wang L, Chorev M, Feingers J, Levitzki A, Inbar M . Stereospecific antibodies to propranolol. FEBS Lett. 1986; 199(2):173-8. DOI: 10.1016/0014-5793(86)80474-4. View

12.

Graves S . Endogenous digitalis-like factors. Crit Rev Clin Lab Sci. 1986; 23(3):177-200. DOI: 10.3109/10408368609165799. View

13.

Quesniaux V, Tees R, SCHREIER M, Wenger R, Van Regenmortel M . Fine specificity and cross-reactivity of monoclonal antibodies to cyclosporine. Mol Immunol. 1987; 24(11):1159-68. DOI: 10.1016/0161-5890(87)90162-3. View

14.

De Blas A, Sangameswaran L, Haney S, Park D, Abraham Jr C, Rayner C . Monoclonal antibodies to benzodiazepines. J Neurochem. 1985; 45(6):1748-53. DOI: 10.1111/j.1471-4159.1985.tb10530.x. View

15.

Holmes N, Parham P . Enhancement of monoclonal antibodies against HLA-A2 is due to antibody bivalency. J Biol Chem. 1983; 258(3):1580-6. View

16.

Morel A, Darmon M, DELAAGE M . Recognition of imidazole and histamine derivatives by monoclonal antibodies. Mol Immunol. 1990; 27(10):995-1000. DOI: 10.1016/0161-5890(90)90122-g. View

17.

Wahyono D, Piechaczyk M, Mourton C, Bastide J, Pau B . Novel anti-digoxin monoclonal antibodies with different binding specificities for digoxin metabolites and other glycosides. Hybridoma. 1990; 9(6):619-29. DOI: 10.1089/hyb.1990.9.619. View

18.

Zalcberg J, Healey K, Hurrell J, McKenzie I . Monoclonal antibodies to drugs--digoxin. Int J Immunopharmacol. 1983; 5(5):397-402. DOI: 10.1016/0192-0561(83)90014-0. View

19.

Scherrmann J, Boudet L, Pontikis R, Nguyen H, Fournier E . A sensitive radioimmunoassay for colchicine. J Pharm Pharmacol. 1980; 32(11):800-2. DOI: 10.1111/j.2042-7158.1980.tb13076.x. View

20.

Yiannakou L, Souvatzoglou A, Diamandis E . Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances. Ther Drug Monit. 1990; 12(2):195-200. DOI: 10.1097/00007691-199003000-00015. View